Pilot study on multidrug resistant tuberculosis in Nigeria
Background: Drug resistant tuberculosis (TB) has lately emerged and it represents a serious public health problem. We set out to determine drug resistance among TB patients. Methods: Using automated BACTEC cultures, multidrug resistant-tuberculosis (MDR-TB) was investigated in 117 diagnosed cases in...
Gespeichert in:
| Veröffentlicht in: | Annals of African medicine 2010-07, Vol.9 (3), p.184-187 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 187 |
|---|---|
| container_issue | 3 |
| container_start_page | 184 |
| container_title | Annals of African medicine |
| container_volume | 9 |
| creator | Lawson, L Habib, A. G Okobi, M. I Idiong, D Olajide, I Emenyonu, N Onuoha, N Cuevas, L. E Ogiri, S. O |
| description | Background: Drug resistant tuberculosis (TB) has lately emerged and it
represents a serious public health problem. We set out to determine
drug resistance among TB patients. Methods: Using automated BACTEC
cultures, multidrug resistant-tuberculosis (MDR-TB) was investigated in
117 diagnosed cases in Abuja, Nigeria. Results: Ten (31%) of 32
culture-positive patients were resistant to at least one and four (13%)
to all of the four drugs tested. No association between drug resistance
and human immunodeficiency virus (HIV) infection was found.
Conclusions: MDR-TB is present in Nigeria and larger studies are
urgently required. TB clinical management and control efforts should be
improved.
Arrière-plan: Résistant aux médicament de la tuberculose
(TB) est apparu récemment et il représente un problème
sérieux pour la santé publique. Nous exposons à afin de
déterminer la résistance aux médicaments parmi les
tuberculeux. Méthodes: Utilisation automatisée BACTEC
cultures Multi-drug résistant-la tuberculose (TB-MR) a
été étudiée dans 117 cas diagnostiqués à
Abuja, Nigéria. Résultats: 10 (31%) des patients de la
culture-positif 32 étaient résistants au moins et 4 (13%)
à l'ensemble des quatre médicaments testés. Aucune
association entre l'infection par le virus
d'immunodéficience humaines (VIH) et de résistance aux
médicaments a été trouvée. Conclusions: TB-MR est
présent au Nigeria et grandes études sont nécessaires de
toute urgence. Efforts de gestion et de contrôle cliniques TB
devraient être améliorées. |
| doi_str_mv | 10.4103/1596-3519.68355 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_748953306</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A235827279</galeid><sourcerecordid>A235827279</sourcerecordid><originalsourceid>FETCH-LOGICAL-b460t-4bf4ff6b667b6751770cc455b24d393d881a6b813d2a1d9e412ec921dcd69e9e3</originalsourceid><addsrcrecordid>eNptks9rFDEcxYNY7LZ69iaDgp5mm9-Z9FaK1UJRD3oOmSSzTclMan4c-t-b7barlZJA4OXzvrzwAsBbBNcUQXKCmOQ9YUiu-UAYewFWUArWM8HpS7Da3x6Co5xvIKSMcfYKHGIoEEQIr8DpDx9i6XKp9q6LSzfXULxNddMll30ueildqaNLpobYhM4v3Te_ccnr1-Bg0iG7Nw_nMfh18fnn-df-6vuXy_Ozq36kHJaejhOdJj5yLkYuGBICGtOCjJhaIokdBqT5OCBisUZWOoqwMxIjayyXTjpyDD7t5t6m-Lu6XNTss3Eh6MXFmpWgg2SEQN7I9_-RN7GmpYVTA5Wc4oGSBn3YQRsdnPLLFEvSZjtSnWHCBiywkI1aP0O1Zd3sTVzc5Jv-xPDxH8O106Fc5xhq8XHJT8GTHWhSzDm5Sd0mP-t0pxBU21LVtja1rU3dl9oc7x6eVcfZ2T3_2OLfsKOPwS9uT5hWk3oU9dw2ap8AkT_NuamU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>849642843</pqid></control><display><type>article</type><title>Pilot study on multidrug resistant tuberculosis in Nigeria</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Bioline International</source><creator>Lawson, L ; Habib, A. G ; Okobi, M. I ; Idiong, D ; Olajide, I ; Emenyonu, N ; Onuoha, N ; Cuevas, L. E ; Ogiri, S. O</creator><creatorcontrib>Lawson, L ; Habib, A. G ; Okobi, M. I ; Idiong, D ; Olajide, I ; Emenyonu, N ; Onuoha, N ; Cuevas, L. E ; Ogiri, S. O</creatorcontrib><description>Background: Drug resistant tuberculosis (TB) has lately emerged and it
represents a serious public health problem. We set out to determine
drug resistance among TB patients. Methods: Using automated BACTEC
cultures, multidrug resistant-tuberculosis (MDR-TB) was investigated in
117 diagnosed cases in Abuja, Nigeria. Results: Ten (31%) of 32
culture-positive patients were resistant to at least one and four (13%)
to all of the four drugs tested. No association between drug resistance
and human immunodeficiency virus (HIV) infection was found.
Conclusions: MDR-TB is present in Nigeria and larger studies are
urgently required. TB clinical management and control efforts should be
improved.
Arrière-plan: Résistant aux médicament de la tuberculose
(TB) est apparu récemment et il représente un problème
sérieux pour la santé publique. Nous exposons à afin de
déterminer la résistance aux médicaments parmi les
tuberculeux. Méthodes: Utilisation automatisée BACTEC
cultures Multi-drug résistant-la tuberculose (TB-MR) a
été étudiée dans 117 cas diagnostiqués à
Abuja, Nigéria. Résultats: 10 (31%) des patients de la
culture-positif 32 étaient résistants au moins et 4 (13%)
à l'ensemble des quatre médicaments testés. Aucune
association entre l'infection par le virus
d'immunodéficience humaines (VIH) et de résistance aux
médicaments a été trouvée. Conclusions: TB-MR est
présent au Nigeria et grandes études sont nécessaires de
toute urgence. Efforts de gestion et de contrôle cliniques TB
devraient être améliorées.</description><identifier>ISSN: 1596-3519</identifier><identifier>EISSN: 0975-5764</identifier><identifier>DOI: 10.4103/1596-3519.68355</identifier><identifier>PMID: 20710112</identifier><language>eng</language><publisher>India: Annals of African Medicine Society</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antitubercular Agents - therapeutic use ; Bacteria ; Diagnosis ; Drug resistance in microorganisms ; Drug resistance, human immunodeficiency virus, prevalence, Nigeria, tuberculosis ; Drug Resistance, Microbial ; Drug therapy ; Female ; Health aspects ; HIV Infections - diagnosis ; HIV Infections - epidemiology ; Humans ; Leprosy ; Male ; Middle Aged ; Mortality ; Mycobacterium tuberculosis - isolation & purification ; Nigeria - epidemiology ; Pilot Projects ; Prevalence ; Quality control ; Risk Factors ; Résistance au virus de l'immunodéficience humaine, prévalence, Nigéria, la tuberculose, la drogue ; Sputum - microbiology ; Standard deviation ; Studies ; Treatment Outcome ; Tuberculosis ; Tuberculosis, Multidrug-Resistant - drug therapy ; Tuberculosis, Multidrug-Resistant - epidemiology ; Tuberculosis, Pulmonary - diagnosis ; Tuberculosis, Pulmonary - drug therapy ; Tuberculosis, Pulmonary - epidemiology ; Tuberculosis, Pulmonary - microbiology ; Young Adult</subject><ispartof>Annals of African medicine, 2010-07, Vol.9 (3), p.184-187</ispartof><rights>Copyright 2010 Annals of African Medicine.</rights><rights>COPYRIGHT 2010 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications & Media Pvt. Ltd. Sep 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b460t-4bf4ff6b667b6751770cc455b24d393d881a6b813d2a1d9e412ec921dcd69e9e3</citedby><cites>FETCH-LOGICAL-b460t-4bf4ff6b667b6751770cc455b24d393d881a6b813d2a1d9e412ec921dcd69e9e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912,79183</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20710112$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lawson, L</creatorcontrib><creatorcontrib>Habib, A. G</creatorcontrib><creatorcontrib>Okobi, M. I</creatorcontrib><creatorcontrib>Idiong, D</creatorcontrib><creatorcontrib>Olajide, I</creatorcontrib><creatorcontrib>Emenyonu, N</creatorcontrib><creatorcontrib>Onuoha, N</creatorcontrib><creatorcontrib>Cuevas, L. E</creatorcontrib><creatorcontrib>Ogiri, S. O</creatorcontrib><title>Pilot study on multidrug resistant tuberculosis in Nigeria</title><title>Annals of African medicine</title><addtitle>Ann Afr Med</addtitle><description>Background: Drug resistant tuberculosis (TB) has lately emerged and it
represents a serious public health problem. We set out to determine
drug resistance among TB patients. Methods: Using automated BACTEC
cultures, multidrug resistant-tuberculosis (MDR-TB) was investigated in
117 diagnosed cases in Abuja, Nigeria. Results: Ten (31%) of 32
culture-positive patients were resistant to at least one and four (13%)
to all of the four drugs tested. No association between drug resistance
and human immunodeficiency virus (HIV) infection was found.
Conclusions: MDR-TB is present in Nigeria and larger studies are
urgently required. TB clinical management and control efforts should be
improved.
Arrière-plan: Résistant aux médicament de la tuberculose
(TB) est apparu récemment et il représente un problème
sérieux pour la santé publique. Nous exposons à afin de
déterminer la résistance aux médicaments parmi les
tuberculeux. Méthodes: Utilisation automatisée BACTEC
cultures Multi-drug résistant-la tuberculose (TB-MR) a
été étudiée dans 117 cas diagnostiqués à
Abuja, Nigéria. Résultats: 10 (31%) des patients de la
culture-positif 32 étaient résistants au moins et 4 (13%)
à l'ensemble des quatre médicaments testés. Aucune
association entre l'infection par le virus
d'immunodéficience humaines (VIH) et de résistance aux
médicaments a été trouvée. Conclusions: TB-MR est
présent au Nigeria et grandes études sont nécessaires de
toute urgence. Efforts de gestion et de contrôle cliniques TB
devraient être améliorées.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antitubercular Agents - therapeutic use</subject><subject>Bacteria</subject><subject>Diagnosis</subject><subject>Drug resistance in microorganisms</subject><subject>Drug resistance, human immunodeficiency virus, prevalence, Nigeria, tuberculosis</subject><subject>Drug Resistance, Microbial</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Health aspects</subject><subject>HIV Infections - diagnosis</subject><subject>HIV Infections - epidemiology</subject><subject>Humans</subject><subject>Leprosy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Mycobacterium tuberculosis - isolation & purification</subject><subject>Nigeria - epidemiology</subject><subject>Pilot Projects</subject><subject>Prevalence</subject><subject>Quality control</subject><subject>Risk Factors</subject><subject>Résistance au virus de l'immunodéficience humaine, prévalence, Nigéria, la tuberculose, la drogue</subject><subject>Sputum - microbiology</subject><subject>Standard deviation</subject><subject>Studies</subject><subject>Treatment Outcome</subject><subject>Tuberculosis</subject><subject>Tuberculosis, Multidrug-Resistant - drug therapy</subject><subject>Tuberculosis, Multidrug-Resistant - epidemiology</subject><subject>Tuberculosis, Pulmonary - diagnosis</subject><subject>Tuberculosis, Pulmonary - drug therapy</subject><subject>Tuberculosis, Pulmonary - epidemiology</subject><subject>Tuberculosis, Pulmonary - microbiology</subject><subject>Young Adult</subject><issn>1596-3519</issn><issn>0975-5764</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>RBI</sourceid><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptks9rFDEcxYNY7LZ69iaDgp5mm9-Z9FaK1UJRD3oOmSSzTclMan4c-t-b7barlZJA4OXzvrzwAsBbBNcUQXKCmOQ9YUiu-UAYewFWUArWM8HpS7Da3x6Co5xvIKSMcfYKHGIoEEQIr8DpDx9i6XKp9q6LSzfXULxNddMll30ueildqaNLpobYhM4v3Te_ccnr1-Bg0iG7Nw_nMfh18fnn-df-6vuXy_Ozq36kHJaejhOdJj5yLkYuGBICGtOCjJhaIokdBqT5OCBisUZWOoqwMxIjayyXTjpyDD7t5t6m-Lu6XNTss3Eh6MXFmpWgg2SEQN7I9_-RN7GmpYVTA5Wc4oGSBn3YQRsdnPLLFEvSZjtSnWHCBiywkI1aP0O1Zd3sTVzc5Jv-xPDxH8O106Fc5xhq8XHJT8GTHWhSzDm5Sd0mP-t0pxBU21LVtja1rU3dl9oc7x6eVcfZ2T3_2OLfsKOPwS9uT5hWk3oU9dw2ap8AkT_NuamU</recordid><startdate>20100701</startdate><enddate>20100701</enddate><creator>Lawson, L</creator><creator>Habib, A. G</creator><creator>Okobi, M. I</creator><creator>Idiong, D</creator><creator>Olajide, I</creator><creator>Emenyonu, N</creator><creator>Onuoha, N</creator><creator>Cuevas, L. E</creator><creator>Ogiri, S. O</creator><general>Annals of African Medicine Society</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><scope>RBI</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20100701</creationdate><title>Pilot study on multidrug resistant tuberculosis in Nigeria</title><author>Lawson, L ; Habib, A. G ; Okobi, M. I ; Idiong, D ; Olajide, I ; Emenyonu, N ; Onuoha, N ; Cuevas, L. E ; Ogiri, S. O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b460t-4bf4ff6b667b6751770cc455b24d393d881a6b813d2a1d9e412ec921dcd69e9e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antitubercular Agents - therapeutic use</topic><topic>Bacteria</topic><topic>Diagnosis</topic><topic>Drug resistance in microorganisms</topic><topic>Drug resistance, human immunodeficiency virus, prevalence, Nigeria, tuberculosis</topic><topic>Drug Resistance, Microbial</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Health aspects</topic><topic>HIV Infections - diagnosis</topic><topic>HIV Infections - epidemiology</topic><topic>Humans</topic><topic>Leprosy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Mycobacterium tuberculosis - isolation & purification</topic><topic>Nigeria - epidemiology</topic><topic>Pilot Projects</topic><topic>Prevalence</topic><topic>Quality control</topic><topic>Risk Factors</topic><topic>Résistance au virus de l'immunodéficience humaine, prévalence, Nigéria, la tuberculose, la drogue</topic><topic>Sputum - microbiology</topic><topic>Standard deviation</topic><topic>Studies</topic><topic>Treatment Outcome</topic><topic>Tuberculosis</topic><topic>Tuberculosis, Multidrug-Resistant - drug therapy</topic><topic>Tuberculosis, Multidrug-Resistant - epidemiology</topic><topic>Tuberculosis, Pulmonary - diagnosis</topic><topic>Tuberculosis, Pulmonary - drug therapy</topic><topic>Tuberculosis, Pulmonary - epidemiology</topic><topic>Tuberculosis, Pulmonary - microbiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lawson, L</creatorcontrib><creatorcontrib>Habib, A. G</creatorcontrib><creatorcontrib>Okobi, M. I</creatorcontrib><creatorcontrib>Idiong, D</creatorcontrib><creatorcontrib>Olajide, I</creatorcontrib><creatorcontrib>Emenyonu, N</creatorcontrib><creatorcontrib>Onuoha, N</creatorcontrib><creatorcontrib>Cuevas, L. E</creatorcontrib><creatorcontrib>Ogiri, S. O</creatorcontrib><collection>Bioline International</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of African medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lawson, L</au><au>Habib, A. G</au><au>Okobi, M. I</au><au>Idiong, D</au><au>Olajide, I</au><au>Emenyonu, N</au><au>Onuoha, N</au><au>Cuevas, L. E</au><au>Ogiri, S. O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pilot study on multidrug resistant tuberculosis in Nigeria</atitle><jtitle>Annals of African medicine</jtitle><addtitle>Ann Afr Med</addtitle><date>2010-07-01</date><risdate>2010</risdate><volume>9</volume><issue>3</issue><spage>184</spage><epage>187</epage><pages>184-187</pages><issn>1596-3519</issn><eissn>0975-5764</eissn><abstract>Background: Drug resistant tuberculosis (TB) has lately emerged and it
represents a serious public health problem. We set out to determine
drug resistance among TB patients. Methods: Using automated BACTEC
cultures, multidrug resistant-tuberculosis (MDR-TB) was investigated in
117 diagnosed cases in Abuja, Nigeria. Results: Ten (31%) of 32
culture-positive patients were resistant to at least one and four (13%)
to all of the four drugs tested. No association between drug resistance
and human immunodeficiency virus (HIV) infection was found.
Conclusions: MDR-TB is present in Nigeria and larger studies are
urgently required. TB clinical management and control efforts should be
improved.
Arrière-plan: Résistant aux médicament de la tuberculose
(TB) est apparu récemment et il représente un problème
sérieux pour la santé publique. Nous exposons à afin de
déterminer la résistance aux médicaments parmi les
tuberculeux. Méthodes: Utilisation automatisée BACTEC
cultures Multi-drug résistant-la tuberculose (TB-MR) a
été étudiée dans 117 cas diagnostiqués à
Abuja, Nigéria. Résultats: 10 (31%) des patients de la
culture-positif 32 étaient résistants au moins et 4 (13%)
à l'ensemble des quatre médicaments testés. Aucune
association entre l'infection par le virus
d'immunodéficience humaines (VIH) et de résistance aux
médicaments a été trouvée. Conclusions: TB-MR est
présent au Nigeria et grandes études sont nécessaires de
toute urgence. Efforts de gestion et de contrôle cliniques TB
devraient être améliorées.</abstract><cop>India</cop><pub>Annals of African Medicine Society</pub><pmid>20710112</pmid><doi>10.4103/1596-3519.68355</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1596-3519 |
| ispartof | Annals of African medicine, 2010-07, Vol.9 (3), p.184-187 |
| issn | 1596-3519 0975-5764 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_748953306 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Bioline International |
| subjects | Adolescent Adult Aged Aged, 80 and over Antitubercular Agents - therapeutic use Bacteria Diagnosis Drug resistance in microorganisms Drug resistance, human immunodeficiency virus, prevalence, Nigeria, tuberculosis Drug Resistance, Microbial Drug therapy Female Health aspects HIV Infections - diagnosis HIV Infections - epidemiology Humans Leprosy Male Middle Aged Mortality Mycobacterium tuberculosis - isolation & purification Nigeria - epidemiology Pilot Projects Prevalence Quality control Risk Factors Résistance au virus de l'immunodéficience humaine, prévalence, Nigéria, la tuberculose, la drogue Sputum - microbiology Standard deviation Studies Treatment Outcome Tuberculosis Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Multidrug-Resistant - epidemiology Tuberculosis, Pulmonary - diagnosis Tuberculosis, Pulmonary - drug therapy Tuberculosis, Pulmonary - epidemiology Tuberculosis, Pulmonary - microbiology Young Adult |
| title | Pilot study on multidrug resistant tuberculosis in Nigeria |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T10%3A12%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pilot%20study%20on%20multidrug%20resistant%20tuberculosis%20in%20Nigeria&rft.jtitle=Annals%20of%20African%20medicine&rft.au=Lawson,%20L&rft.date=2010-07-01&rft.volume=9&rft.issue=3&rft.spage=184&rft.epage=187&rft.pages=184-187&rft.issn=1596-3519&rft.eissn=0975-5764&rft_id=info:doi/10.4103/1596-3519.68355&rft_dat=%3Cgale_proqu%3EA235827279%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=849642843&rft_id=info:pmid/20710112&rft_galeid=A235827279&rfr_iscdi=true |